Recent Finacing
Recent Raise
Georgiamune is a clinical-stage biotechnology company in Gaithersburg developing immune-signaling–reprogramming therapies, including dual-function monoclonal antibody GIM-122 with FDA-cleared IND and planned phase 1/2 trials for advanced solid tumors.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
